PRM-PA:CA Big Pharma Split Corp

CAD 9.60 0.00 0
Icon

Big Pharma Split Corp (PRM-PA:CA) Stock Analysis and Price Targets

COMMON STOCK | Asset Management | TSX
stockTargetAdvisor

N/A

Average Analyst
Rating
stockTargetAdvisor

N/A

Top Analyst
Rating
stockTargetAdvisor

Slightly Bullish

Stock Target Advisor
Analysis
stockTargetAdvisor

N/A

Average User
Rating

CAD 9.60

0.00 (0.00)%

N/A

500.00

N/A

N/A

Icon

PRM-PA:CA

Big Pharma Split Corp (CAD)
COMMON STOCK | TSX
CAD 9.60
0.00 0
Take a Tour
stockTargetAdvisor

N/A

Average Analyst
Rating
stockTargetAdvisor

N/A

Top Analyst
Rating
stockTargetAdvisor

Slightly Bullish

Stock Target Advisor
Analysis
stockTargetAdvisor

N/A

Average User
Rating

N/A

N/A

CAD 9.60

Big Pharma Split Corp (PRM-PA:CA) Stock Forecast

N/A

Based on the Big Pharma Split Corp stock forecast from 0 analysts, the average analyst target price for Big Pharma Split Corp is not available over the next 12 months. Big Pharma Split Corp’s average analyst rating is not available. Stock Target Advisor’s own stock analysis of Big Pharma Split Corp is Slightly Bullish , which is based on 4 positive signals and 3 negative signals. At the last closing, Big Pharma Split Corp’s stock price was CAD 9.60. Big Pharma Split Corp’s stock price has changed by +0.10% over the past week, +1.05% over the past month and -2.54% over the last year.

No recent analyst target price found for Big Pharma Split Corp
No recent average analyst rating found for Big Pharma Split Corp

Company Overview Big Pharma Split Corp

Big Pharma Split Corp is a closed ended equity mutual fund launched and managed by Harvest Portfolios Group Inc. It invests in the public equity markets across United States. The fund primarily invests in the Pharmaceutical sector. Big Pharma Split Corp was formed on September 15...Read More

610 Chartwell Road, Oakville, ON, Canada, L6j 4A5

0

December

CAD

Canada

Adjusted Closing Price for Big Pharma Split Corp (PRM-PA:CA)

Loading...

Unadjusted Closing Price for Big Pharma Split Corp (PRM-PA:CA)

Loading...

Share Trading Volume for Big Pharma Split Corp Shares

Loading...

Compare Performance of Big Pharma Split Corp Shares

Symbol Capital Gain Dividend Return Total Return
Loading...
Loading...

Technical Indicators for PRM-PA:CA

Assets

Top Holdings

Top Sectors

Top Regions

Stocks Similar To Big Pharma Split Corp (Sector: Asset Management )

Symbol Name Price(Change) Market Cap Price / Earning Ratio EV/EBITDA
BN:CA
Brookfield Corporation 0.00 (0.00%) CAD87.87B 67.81 12.88

ETFs Containing PRM-PA:CA

Symbol Name PRM-PA:CA's Weight Expense Ratio Price(Change) Market Cap
no data

Frequently Asked Questions About Big Pharma Split Corp (PRM-PA:CA) Stock

Stock Target Advisor's fundamental analysis for Big Pharma Split Corp's stock is Slightly Bullish .

PRM-PA:CA stock's dividend yield is 5.25%. Our analysis grades PRM-PA:CA stock's dividend yield at F. This means that PRM-PA:CA stock's dividend yield is above 27% of the stocks in the Asset Management sector in the TSX exchange. Based on this PRM-PA:CA may be a poor dividend stock for its sector.

Unfortunately we do not have enough data on PRM-PA:CA's stock to indicate what its average analyst target is.

PRM-PA:CA stock's Price/Earning ratio is 2.92. Our analysis grades PRM-PA:CA stock's Price / Earning ratio at C+. This means that PRM-PA:CA stock's Price/Earning ratio is above 23% of the stocks in the Asset Management sector in the TSX exchange. Based on this PRM-PA:CA may be undervalued for its sector.

The last closing price of PRM-PA:CA's stock was CAD 9.60.

Unfortunately we do not currently have any market capitalization data for PRM-PA:CA's stock.

Unfortunately we do not have enough analyst data on PRM-PA:CA's stock to indicate whether its price will go up or not.

We can't find any ETFs which contains Big Pharma Split Corp's stock.

As per our most recent records Big Pharma Split Corp has 0 Employees.

Big Pharma Split Corp's registered address is 610 Chartwell Road, Oakville, ON, Canada, L6j 4A5. You can get more information about it from Big Pharma Split Corp's website at https://www.harvestportfolios.com/closed-end-funds.
Heading 1 Heading 2 Heading 3 Heading 4 Heading 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5

Stock Target Advisor's Analysis

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

Icon
What to like

Icon
What not to like

Loading...